Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem,
Jorge Mansilla-Soto,
Theodoros Giavridis,
Sjoukje J. C. van der Stegen,
Mohamad Hamieh,
Kristen M. Cunanan,
Ashlesha Odak,
Mithat Gönen and
Michel Sadelain ()
Additional contact information
Justin Eyquem: Center for Cell Engineering and Immunology Program
Jorge Mansilla-Soto: Center for Cell Engineering and Immunology Program
Theodoros Giavridis: Center for Cell Engineering and Immunology Program
Sjoukje J. C. van der Stegen: Center for Cell Engineering and Immunology Program
Mohamad Hamieh: Center for Cell Engineering and Immunology Program
Kristen M. Cunanan: Memorial Sloan Kettering Cancer Center
Ashlesha Odak: Center for Cell Engineering and Immunology Program
Mithat Gönen: Memorial Sloan Kettering Cancer Center
Michel Sadelain: Center for Cell Engineering and Immunology Program
Nature, 2017, vol. 543, issue 7643, 113-117
Abstract:
Introducing chimeric antigen receptors into the endogenous T-cell receptor locus reduces tonic signalling, averts accelerated T-cell differentiation and delays T-cell exhaustion, leading to enhanced function and anti-tumour efficacy compared to random integrations.
Date: 2017
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/nature21405 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:543:y:2017:i:7643:d:10.1038_nature21405
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nature21405
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().